Repare Therapeutics (RPTX) Revenue (2019 - 2025)
Repare Therapeutics (RPTX) revenue from Jun 30, 2019 to Sep 30, 2025. The TTM Repare Therapeutics (RPTX) revenue is $7.02M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Repare Therapeutics (RPTX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -38.85% |
| 3 Years TTM | +35.85% |
| 5 Years TTM | +113.03% |
Annual Revenue change of Repare Therapeutics (RPTX)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $5M | -51.88% |
| 2024 | $10M | -22.06% |
| 2023 | $13M | +136.77% |
| 2022 | $5.63M | +2065.38% |
| 2021 | $260K | +8.33% |
| 2020 | $240K | N/A |
| 2019 | $0 | N/A |
Comparison Repare Therapeutics (RPTX) five years revenue CAGR with competitors
Repare Therapeutics (RPTX) five years revenue CAGR is 114.08%.